Suppr超能文献

针刺对有疼痛的乳腺癌幸存者的镇痛药和医疗资源利用的真实世界影响。

Real-world impact of acupuncture on analgesics and healthcare resource utilization in breast cancer survivors with pain.

机构信息

School of Pharmacy & Pharmaceutical Sciences, University of California Irvine, 802 W Peltason Dr, Irvine, CA, 92697-4625, USA.

School of Pharmacy, Chapman University, RK 94-206, 9401 Jeronimo Road, Irvine, CA, 92618, USA.

出版信息

BMC Med. 2024 Sep 16;22(1):394. doi: 10.1186/s12916-024-03626-2.

Abstract

BACKGROUND

This study evaluated the real-world impact of acupuncture on analgesics and healthcare resource utilization among breast cancer survivors.

METHODS

From a United States (US) commercial claims database (25% random sample of IQVIA PharMetrics® Plus for Academics), we selected 18-63 years old malignant breast cancer survivors experiencing pain and ≥ 1 year removed from cancer diagnosis. Using the difference-in-difference technique, annualized changes in analgesics [prevalence, rates of short-term (< 30-day supply) and long-term (≥ 30-day supply) prescription fills] and healthcare resource utilization (healthcare costs, hospitalizations, and emergency department visits) were compared between acupuncture-treated and non-treated patients.

RESULTS

Among 495 (3%) acupuncture-treated patients (median age: 55 years, stage 4: 12%, average 2.5 years post cancer diagnosis), most had commercial health insurance (92%) and experiencing musculoskeletal pain (98%). Twenty-seven percent were receiving antidepressants and 3% completed ≥ 2 long-term prescription fills of opioids. Prevalence of opioid usage reduced from 29 to 19% (P < 0.001) and NSAID usage reduced from 21 to 14% (P = 0.001) post-acupuncture. The relative prevalence of opioid and NSAID use decreased by 20% (P < 0.05) and 19% (P = 0.07), respectively, in the acupuncture-treated group compared to non-treated patients (n = 16,129). However, the reductions were not statistically significant after adjustment for confounding. Patients receiving acupuncture for pain (n = 264, 53%) were found with a relative decrease by 47% and 49% (both P < 0.05) in short-term opioid and NSAID fills compared to those treated for other conditions. High-utilization patients (≥ 10 acupuncture sessions, n = 178, 36%) were observed with a significant reduction in total healthcare costs (P < 0.001) unlike low-utilization patients.

CONCLUSIONS

Although adjusted results did not show that patients receiving acupuncture had better outcomes than non-treated patients, exploratory analyses revealed that patients treated specifically for pain used fewer analgesics and those with high acupuncture utilization incurred lower healthcare costs. Further studies are required to examine acupuncture effectiveness in real-world settings.

摘要

背景

本研究评估了针灸对乳腺癌幸存者的镇痛药物和医疗资源利用的实际影响。

方法

我们从美国(美国)商业索赔数据库(IQVIA PharMetrics® Plus for Academics 的 25%随机样本)中选择了 18-63 岁患有疼痛且癌症诊断后≥1 年的恶性乳腺癌幸存者。使用差异法,比较了针灸治疗和非治疗患者之间的镇痛药物(患病率、短期(<30 天供应量)和长期(≥30 天供应量)处方的使用率)和医疗资源利用(医疗费用、住院和急诊就诊)的年化变化。

结果

在 495 名(3%)接受针灸治疗的患者(中位数年龄:55 岁,4 期:12%,平均癌症诊断后 2.5 年)中,大多数人拥有商业健康保险(92%),并患有肌肉骨骼疼痛(98%)。27%的人正在服用抗抑郁药,3%的人完成了≥2 次长期阿片类药物处方。阿片类药物使用率从 29%降至 19%(P<0.001),非甾体抗炎药使用率从 21%降至 14%(P=0.001)。与未接受治疗的患者(n=16,129)相比,针灸治疗组阿片类药物和非甾体抗炎药的相对使用率分别降低了 20%(P<0.05)和 19%(P=0.07)。然而,在调整混杂因素后,这些差异无统计学意义。接受针灸治疗疼痛的患者(n=264,53%)的短期阿片类药物和非甾体抗炎药处方使用率分别相对降低了 47%和 49%(均 P<0.05),与治疗其他疾病的患者相比。与低利用率患者(n=178,36%)相比,高利用率患者(≥10 次针灸治疗)的总医疗费用显著降低(P<0.001)。

结论

尽管调整后的结果显示接受针灸治疗的患者与未接受治疗的患者相比,结果没有改善,但探索性分析显示,专门接受疼痛治疗的患者使用的镇痛药较少,而高利用率的患者医疗费用较低。需要进一步研究来检查针灸在现实环境中的有效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/498e/11406884/574097ab445a/12916_2024_3626_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验